Media

Bioscience industry a bright spot among the technology sector
The 2014 BIO International Convention, where the global biotech community meets, connecting the people, companies and innovations that help to fulfill the...

Press Releases

Apr 14 2000
WASHINGTON, D.C. (April 14, 2000) The BiotechnologyIndustry Organization (BIO) has put together a coalition of entrepreneurial associations to support full...
Apr 13 2000
WASHINGTON (APRIL 13, 2000)-- We commend the work of the House subcommittee report which encompasses the research and testimony of distinguished scientists who...
Apr 12 2000
WASHINGTON, D.C., (April 12, 2000) Nancy Bradish Myers, health-care policy and reimbursement counsel for the Biotechnology Industry Organization (BIO), issued...
Apr 5 2000
(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) today made the following comments in response to...
Apr 5 2000
WASHINGTON (April 5, 2000) Recommendations put forth today in a National Research Council report entitled Genetically Modified Pest Protected Plants: Science...
Apr 5 2000
WASHINGTON, D.C. (April 5, 2000) The Biotechnology Industry Organization (BIO) applauded President Clinton for comments today clarifying his March 14 joint...
Apr 4 2000
WASHINGTON (April 3, 2000) The Biotechnology Industry Organization (BIO) today announced as chairman of the board of directors, Mark Skaletsky, president and...
Apr 4 2000
(Carl B. Feldbaum, president of BIO, today issued the following statement regarding a request by Reps. Dennis Kucinich (D-Ohio) and Jack Metcalf (R-Wash.) to...
Apr 3 2000
Washington - April 3, 2000 - A multi-year, industry-led public information program begins today to share information about agricultural biotechnology with...


Biotechnology News

July 30, 2014

SEATTLE--(BUSINESS WIRE)--Theraclone and Gilead enter into exclusive agreement for therapeutic applications for Theraclone's broadly neutralizing HIV antibodies.

July 30, 2014

ITINGEN, Switzerland--(BUSINESS WIRE)--Harlan Laboratories, Ltd. is prepared to meet the global demand for development programs in novel biologics and biosimilars.

July 30, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group (NYSE MKT: XXII) today announced that the U.S. Patent and Trademark Office granted a patent to the Company for its NBB...

July 30, 2014

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. prices offering.

July 30, 2014

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries,...